190 related articles for article (PubMed ID: 33492646)
21. Positron Emission Tomography (PET) and breast cancer in clinical practice.
Lavayssière R; Cabée AE; Filmont JE
Eur J Radiol; 2009 Jan; 69(1):50-8. PubMed ID: 18814983
[TBL] [Abstract][Full Text] [Related]
22. Integrated PET/MR breast cancer imaging: Attenuation correction and implementation of a 16-channel RF coil.
Oehmigen M; Lindemann ME; Lanz T; Kinner S; Quick HH
Med Phys; 2016 Aug; 43(8):4808. PubMed ID: 27487899
[TBL] [Abstract][Full Text] [Related]
23. Classification of Abnormal Findings on Ring-type Dedicated Breast PET for the Detection of Breast Cancer.
Sasada S; Masumoto N; Kimura Y; Emi A; Kadoya T; Okada M
Anticancer Res; 2020 Jun; 40(6):3491-3497. PubMed ID: 32487649
[TBL] [Abstract][Full Text] [Related]
24. The Japanese Breast Cancer Society clinical practice guidelines for screening and imaging diagnosis of breast cancer, 2015 edition.
Tozaki M; Kuroki Y; Kikuchi M; Kojima Y; Kubota K; Nakahara H; Ito Y; Mukai H
Breast Cancer; 2016 May; 23(3):357-66. PubMed ID: 27052720
[No Abstract] [Full Text] [Related]
25. Performance of dedicated breast positron emission tomography in the detection of small and low-grade breast cancer.
Sueoka S; Sasada S; Masumoto N; Emi A; Kadoya T; Okada M
Breast Cancer Res Treat; 2021 May; 187(1):125-133. PubMed ID: 33484374
[TBL] [Abstract][Full Text] [Related]
26. Texture analysis of high-resolution dedicated breast
Moscoso A; Ruibal Á; Domínguez-Prado I; Fernández-Ferreiro A; Herranz M; Albaina L; Argibay S; Silva-Rodríguez J; Pardo-Montero J; Aguiar P
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):196-206. PubMed ID: 28936601
[TBL] [Abstract][Full Text] [Related]
27. Unexpected Abnormal Uptake in the Breasts at Dedicated Breast PET: Incidentally Detected Small Cancers or Nonmalignant Features?
Satoh Y; Motosugi U; Omiya Y; Onishi H
AJR Am J Roentgenol; 2019 Feb; 212(2):443-449. PubMed ID: 30476450
[TBL] [Abstract][Full Text] [Related]
28. Effects of system geometry and other physical factors on photon sensitivity of high-resolution positron emission tomography.
Habte F; Foudray AM; Olcott PD; Levin CS
Phys Med Biol; 2007 Jul; 52(13):3753-72. PubMed ID: 17664575
[TBL] [Abstract][Full Text] [Related]
29. The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment.
Yamamoto Y; Yamauchi C; Toyama T; Nagai S; Sakai T; Kutomi G; Yoshimura M; Kawai M; Ohtani S; Kubota K; Nakashima K; Honma N; Yoshida M; Tokunaga E; Taira N; Iwata H; Saji S
Breast Cancer; 2024 May; 31(3):340-346. PubMed ID: 38570435
[TBL] [Abstract][Full Text] [Related]
30. Use of Breast-Specific PET Scanners and Comparison with MR Imaging.
Narayanan D; Berg WA
Magn Reson Imaging Clin N Am; 2018 May; 26(2):265-272. PubMed ID: 29622131
[TBL] [Abstract][Full Text] [Related]
31. High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer.
Berg WA; Weinberg IN; Narayanan D; Lobrano ME; Ross E; Amodei L; Tafra L; Adler LP; Uddo J; Stein W; Levine EA;
Breast J; 2006; 12(4):309-23. PubMed ID: 16848840
[TBL] [Abstract][Full Text] [Related]
32. The feasibility of dedicated breast PET for the assessment of residual tumor after neoadjuvant chemotherapy.
Koyasu H; Goshima S; Noda Y; Nishibori H; Takeuchi M; Matsunaga K; Yamada T; Matsuo M
Jpn J Radiol; 2019 Jan; 37(1):81-87. PubMed ID: 30392134
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer staging in a single session: whole-body PET/CT mammography.
Heusner TA; Kuemmel S; Umutlu L; Koeninger A; Freudenberg LS; Hauth EA; Kimmig KR; Forsting M; Bockisch A; Antoch G
J Nucl Med; 2008 Aug; 49(8):1215-22. PubMed ID: 18632831
[TBL] [Abstract][Full Text] [Related]
34. Detection of breast cancer in an FDG-PET cancer screening program: results of a nationwide Japanese survey.
Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Inoue T
Clin Breast Cancer; 2015 Apr; 15(2):e139-46. PubMed ID: 25454690
[TBL] [Abstract][Full Text] [Related]
35. Advances in Breast PET Instrumentation.
Krishnamoorthy S; Surti S
PET Clin; 2024 Jan; 19(1):37-47. PubMed ID: 37949606
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the Response to Breast Cancer Neoadjuvant Chemotherapy Using 18F-FDG Positron Emission Mammography Compared With Whole-Body 18F-FDG PET: A Prospective Observational Study.
Noritake M; Narui K; Kaneta T; Sugae S; Sakamaki K; Inoue T; Ishikawa T
Clin Nucl Med; 2017 Mar; 42(3):169-175. PubMed ID: 28072617
[TBL] [Abstract][Full Text] [Related]
37. [Understanding positon emission tomography (PET) with [18F]-FDG in clinical oncology. Informations dedicated to patients and relatives].
Bourguet P; Brusco S; Corone C; Devillers A; Foehrenbach H; Lumbroso JD; Maszelin P; Montravers F; Moretti JL; Rain JD; Talbot JN; Carretier J; Leichtnam-Dugarin L; Delavigne V; Philip T; Fervers B; ; ; ; ; ; ;
Bull Cancer; 2005 Jul; 92(7):723-32. PubMed ID: 16123010
[TBL] [Abstract][Full Text] [Related]
38. Whole-body
Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
[TBL] [Abstract][Full Text] [Related]
39. Positron emission tomography in diagnosis and management of invasive breast cancer: current status and future perspectives.
Wu D; Gambhir SS
Clin Breast Cancer; 2003 Apr; 4 Suppl 1():S55-63. PubMed ID: 12756080
[TBL] [Abstract][Full Text] [Related]
40. Clinical performance of 2 dedicated PET scanners for breast imaging: initial evaluation.
Iima M; Nakamoto Y; Kanao S; Sugie T; Ueno T; Kawada M; Mikami Y; Toi M; Togashi K
J Nucl Med; 2012 Oct; 53(10):1534-42. PubMed ID: 22933819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
